A peer-reviewed observational cohort study from Karolinska Institutet, published in JAMA Network Open, found that the Modified Checklist for Autism in Toddlers (M-CHAT) failed to detect 38% of high-risk toddlers (primarily younger siblings of children with autism) who later received a confirmed ASD diagnosis. With a moderate sample size focused on this enriched population, the study provides useful but not definitive evidence on real-world screening performance; no conflicts of interest were disclosed.

While the original MedicalXpress coverage accurately reports the miss rate and calls for supplementary methods, it stops short of connecting this to broader, persistent patterns of inadequate neurodevelopmental infrastructure. High-risk cohorts are particularly important because recurrence rates in siblings can reach 20%, yet standard tools like M-CHAT—designed as a quick parent questionnaire—struggle with subtle or atypical presentations often seen in girls or children with co-occurring conditions. This finding aligns with a 2014 large-scale observational study in Pediatrics (n>10,000) showing M-CHAT sensitivity of only 40-60% in community samples, and a 2022 meta-analysis in JAMA Pediatrics that synthesized 15 studies and concluded questionnaire-only approaches consistently underperform in high-risk groups, missing opportunities for intervention during critical developmental windows.

What existing coverage has largely missed is the systemic context: even when screening flags a child, average U.S. and European diagnosis ages remain 4-5 years due to specialist shortages, long waitlists, and fragmented referral pathways. This compounds the problem for the 38% missed entirely, linking directly to underfunded early intervention services that fail to provide timely speech, occupational, or behavioral therapies. The reliance on subjective parent-report tools also introduces bias—parents in high-risk families may over- or under-report based on prior experience—something not adequately addressed by current AAP guidelines that still center M-CHAT at 18- and 24-month visits.

Taken together, these sources reveal a pattern of over-dependence on imperfect, low-cost screens at the expense of multi-method strategies combining direct observation (such as ADOS-2) and longitudinal monitoring. The result is a public health failure that disproportionately affects marginalized communities with less access to private evaluations, perpetuating lifelong disparities in outcomes.